comparemela.com
Home
Live Updates
FDA Committee Votes in Favor of Intranasal Epinephrine for Severe Allergic Reactions Including Anaphylaxis : comparemela.com
FDA Committee Votes in Favor of Intranasal Epinephrine for Severe Allergic Reactions Including Anaphylaxis
It was announced by ARS Pharmaceuticals, Inc., that a US Food and Drug Administration Drug Advisory Committee voted in favor of a new intranasal epinephrine treatment for severe allergic reactions.
Related Keywords
United States ,
Americans ,
Richard Lowenthal ,
Grossig David Dworaczyk ,
Drug Administration ,
Allergy Drug Advisory Committee ,
Advisory Committee Votes In Support Of Favorable ,
Pharmaceuticals Inc ,
Pulmonary Allergy Drug Advisory Committee ,
New Drug Application ,
Drug User Fee Act ,
Chief Executive Officer ,
Committee Votes ,
Favorable Benefit Risk Profile ,
Allergic Reactions ,
Including Anaphylaxis ,
Published May ,
Epinephrine Nasal ,
comparemela.com © 2020. All Rights Reserved.